Core Insights - ENvue Medical Inc. shares experienced a decline during Thursday's premarket session after a significant surge of approximately 17% on Wednesday, attributed to the announcement of the ENvue Navigation Platform [1] Group 1: Product Developments - ENvue Medical announced a major purchase of its ENvue Navigation Platform and feeding tubes by a teaching hospital and Level I Trauma Center in the Detroit metropolitan area, expanding its presence to 39 hospitals across the U.S. [2] - The ENvue system has received FDA 510(k) clearance for adult use, assisting clinicians in safely and efficiently placing feeding tubes [3][5] - The ENvue Navigation Platform is a minimally invasive electromagnetic navigation system that aids in placing feeding tubes into the gastrointestinal tract [4] Group 2: Future Applications and Partnerships - The platform's integration into existing clinical workflows indicates potential future applications in pediatric and vascular access settings [3][5] - In January, ENvue Medical entered a distribution agreement with U-Deliver to distribute its recently launched over-the-counter reusable ENFit Syringes nationwide through non-acute care channels [5] - The over-the-counter ENFit Syringes are designed to meet both feeding and medication delivery clinical needs [6]

Core Insights - ENvue Medical has signed a distribution agreement with U-Deliver to expand access to its ENFit Syringes across non-acute care channels nationwide [1][2] - The partnership aims to enhance ENvue's presence in the non-acute enteral care market, focusing on providing reliable and safe solutions for feeding and medication delivery [2] Company Overview - ENvue Medical, Inc. specializes in intelligent, non-invasive solutions for enteral care in clinical and home care settings, headquartered in Tyler, Texas [4] - The company has a research and development presence in Tel-Aviv and Nesher, Israel, and operates two distinct technology platforms [4] Product Details - ENvue's ENFit Syringes are available in sizes of 2.5 mL, 5 mL, 10 mL, and 60 mL, and do not require a prescription [2] - The syringes meet ISO 80369-3 global standards and can be reused for up to seven days or 20 uses, ensuring safe enteral delivery [2] Partner Overview - U-Deliver is a U.S.-based supplier focused on enteral feeding supplies for home and long-term care settings, serving non-acute care customers through online and distribution channels [3]

Company Overview - ENvue Medical Inc., formerly known as NanoVibronix Inc., specializes in intelligent, non-invasive solutions for enteral care in clinical and home care settings [2] - The rebranding aims to better reflect the company's strategic direction and focus on the ENvue feeding-tube placement system [2] Recent Developments - ENvue Medical has signed a distribution agreement with U-Deliver to distribute its over-the-counter reusable ENFit Syringes nationwide through non-acute care channels [1] - The ENFit Syringes are designed to meet clinical needs for both feeding and medication delivery [1] Product Details - The ENFit Syringes are available in sizes of 2.5 mL, 5 mL, 10 mL, and 60 mL, and can be purchased without a prescription [4] - These syringes can be reused for up to seven days or 20 uses, ensuring safe and consistent enteral delivery in various care environments [4] Market Presence - The partnership with U-Deliver is seen as a significant step in scaling the ENFit syringe line and enhancing ENvue's presence in the non-acute enteral care market [3] - ENvue Medical's stock is currently trading at $1.26, reflecting a 20.124% increase during premarket trading [5]

Core Insights - ENvue Medical, Inc. has launched a new line of over-the-counter ENFit Syringes aimed at enhancing enteral care in both clinical and home settings, addressing the need for reliable and high-quality solutions as care shifts beyond hospitals [1][2] Product Launch - The ENFit Syringes are designed for feeding and medication delivery, available in sizes of 2.5 mL, 5 mL, 10 mL, and 60 mL, and will be sold without a prescription through online retailers like Amazon [2] - These syringes comply with ISO 80369-3 global standards and can be reused for up to seven days or 20 uses, promoting safe and consistent enteral delivery [2] Company Overview - ENvue Medical specializes in intelligent, non-invasive solutions for enteral care, with headquarters in Tyler, Texas, and R&D facilities in Tel-Aviv and Nesher, Israel [3] - The company focuses on two technology platforms: the ENvue Navigation Platform for minimally invasive feeding tube placement and acoustic-based therapeutic technologies like PainShield® and UroShield® [4]